B
Balasamy Thiyagarajan
Researcher at United States Military Academy
Publications - 4
Citations - 2106
Balasamy Thiyagarajan is an academic researcher from United States Military Academy. The author has contributed to research in topics: Losartan & Heart failure. The author has an hindex of 4, co-authored 4 publications receiving 2043 citations. Previous affiliations of Balasamy Thiyagarajan include University of Chicago.
Papers
More filters
Journal ArticleDOI
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
Bertram Pitt,Philip A. Poole-Wilson,Robert Segal,Felipe Martinez,Kenneth Dickstein,A. John Camm,Marvin A. Konstam,Günter A.J. Riegger,George Klinger,James D. Neaton,Divakar Sharma,Balasamy Thiyagarajan +11 more
TL;DR: The ELITE II Losartan Heart Failure Survival Study as discussed by the authors showed an association between the angiotensin II antagonist losartan and an unexpected survival benefit in elderly heart-failure patients, compared with captopril, an ACE inhibitor.
Journal ArticleDOI
Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.
Bertram Pitt,Philip A. Poole-Wilson,Robert Segal,Felipe Martinez,Kenneth Dickstein,A. John Camm,Marvin A. Konstam,Günter A.J. Riegger,George Klinger,James D. Neaton,Divakar Sharma,Balasamy Thiyagarajan +11 more
TL;DR: The ELITE II study will further define the role of losartan in the treatment of patients with symptomatic heart failure relative to the angiotensin-converting enzyme inhibitor captopril, an agent from a class currently considered standard treatment for this disease.
Journal ArticleDOI
Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia.
Shahnaz Shahinfar,Roger L. Simpson,Roger L. Simpson,Alexandra D. Carides,Alexandra D. Carides,Balasamy Thiyagarajan,Balasamy Thiyagarajan,Yasushi Nakagawa,Yasushi Nakagawa,Jason G Umans,Jason G Umans,Joan H. Parks,Joan H. Parks,Fredric L. Coe,Fredric L. Coe +14 more
TL;DR: Losartan decreased serum Uric acid and increased uric acid excretion without increasing urinary dihydrogen urate, the primary risk factor for acute urate nephropathy, during 21 days of dosing in hypertensive patients with thiazide-induced hyperuricemia.
Journal Article
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure
Bertram Pitt,Philip A. Poole-Wilson,Robert Segal,Felipe Martinez,Kenneth Dickstein,A. John Camm,Marvin A. Konstam,Günter A.J. Riegger,George Klinger,James D. Neaton,Divakar Sharma,Balasamy Thiyagarajan +11 more
TL;DR: Whether losartan is superior to captopril in improving survival and is better tolerated and the ELITE II Losartan Heart Failure Survival Study is confirmed.